Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
208 Chapter 16 · Treatment of Lymphoblastic Lymphoma in Adults<br />
After induction, residual MedTu are sometimes difficult<br />
to assess and hamper the confirmation of CR. The mediastinum<br />
is also the most frequent site of recurrence.<br />
Several questions arise from this issue, such as prognostic<br />
impact of residual tumors, useful diagnostic procedures,<br />
and additional directed treatment of MedTu,<br />
which may either be prophylactic or therapeutic.<br />
16.6.1 Prognostic Impact<br />
of Residual Mediastinal Tumors<br />
The rapid achievement of CR had a prognostic impact<br />
in childhood LBL. Three out of 64 T-LBL patients with<br />
complete response at day 33 of induction showed local<br />
progress (5%) compared to three out of 35 (9%) with<br />
only partial remission [7]. In this study, however, the<br />
overall incidence of local progression was very low.<br />
One pediatric study demonstrated an inferior survival<br />
in patients without normalization of chest radiography<br />
after induction [37]. Also in adult T-LBL an inferior outcome<br />
was observed in patients with incomplete response<br />
to induction therapy, which was mainly due to<br />
residual MedTu [11]. On the other hand, in patients<br />
treated with a HD-MTX based regimen none of three<br />
patients with residual mass after induction relapsed<br />
[28].<br />
16.6.2 Diagnostic Procedures<br />
Not surprisingly, in T-LBL patients with large MedTu<br />
often residual structures are detectable after induction<br />
therapy by X-ray or computed tomography (CT). Additional<br />
diagnostic procedures aim to answer the question<br />
whether this is necrotic or scar tissue or whether vital<br />
tumor cells are present. When resection or biopsy was<br />
performed in 10 pediatric T-LBL patients with residual<br />
tumor after induction therapy, necrotic tissue was<br />
found in all cases [7]. Imaging techniques such as positron<br />
emission tomography (PET) are probably not helpful<br />
very early after induction therapy due to the ongoing<br />
effects of the chemotherapy. They are, however, important<br />
for staging at later time-points. Recently it was reported<br />
that persistently positive PET results were highly<br />
predictive for residual or recurrent disease in NHL [38].<br />
In the GMALL studies PET diagnostics are performed in<br />
patients with residual mediastinal structures after induction<br />
and first consolidation.<br />
Altogether there is some evidence that residual Med-<br />
Tu after induction therapy are associated with increased<br />
relapse risk. In addition to the intensification of systemic<br />
chemotherapy, the most frequently discussed<br />
approach for prevention of mediastinal recurrence<br />
and treatment of residual tumors is mediastinal irradiation<br />
(MedRad) with two principally different strategies:<br />
irradiation of all patients with MedTu or irradiation in<br />
patients with residual tumor only.<br />
16.6.3 Mediastinal Irradiation<br />
Mott et al. reported a significant advantage in terms<br />
of DFS for pediatric T-LBL patients with low-dose irradiation<br />
(15 Gy) (66%) compared to 18% for those<br />
without in an early study with probably suboptimal<br />
chemotherapy [39]. Other strategies in childhood T-<br />
LBL included MedRad in case of emergency only [7,<br />
40, 41]. In the latter study the local recurrence rate<br />
(7%) was very low although no MedRad was administered.<br />
This may be due to a more rigorous early application<br />
of cyclophosphamide and ARAC and HD MTX,<br />
specifically designed as “extra compartment protocol”<br />
during consolidation [7]. This is underlined by the results<br />
of an HDMTX-based NHL protocol in adult T-<br />
LBL where only three of 14 relapses occurred in the<br />
mediastinum [28].<br />
In the GMALL series of adult T-LBL, the mediastinal<br />
relapse rate was higher (47% of all relapses), despite an<br />
induction therapy similar to the pediatric approach and<br />
prophylactic MedRad with 24 Gy in 85% of the patients<br />
early during or after induction chemotherapy. Consolidation<br />
with HD-MTX was, however, less intensive. Mediastinal<br />
relapses occurred in patients with complete<br />
resolution of MedTu as well as in those with residual<br />
tumors after induction therapy [11].<br />
In the cohort of the MDACC, the majority (74%) of<br />
patients had received MedRad with 30–39 Gy after eight<br />
cycles of chemotherapy. Three patients progressed before<br />
this time-point and one out of three patients without<br />
MedRad due to other reasons experienced mediastinal<br />
relapse. The mediastinal relapse rate was 12% in<br />
those who had received MedRad [18].<br />
Altogether these findings underline that effective<br />
treatment of MedTu is an important specific issue in<br />
the treatment of adult T-LBL. In pediatric LBL low mediastinal<br />
recurrence rates are achieved by intensive chemotherapy,<br />
which may, however, not be feasible in adult